ALBO
Albireo Pharma Inc
ALBO
ALBO
Delisted
ALBO was delisted on the 2nd of March, 2023.
108 hedge funds and large institutions have $372M invested in Albireo Pharma Inc in 2022 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 45 increasing their positions, 27 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
6% more capital invested
Capital invested by funds: $353M → $372M (+$19.5M)
5% more funds holding
Funds holding: 103 → 108 (+5)
Holders
108
Holding in Top 10
3
Calls
$2.2M
Puts
$1.79M
Top Buyers
| 1 | +$21.5M | |
| 2 | +$9.27M | |
| 3 | +$7.73M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$6.95M |
| 5 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
+$6.1M |
Top Sellers
| 1 | -$20.8M | |
| 2 | -$8.56M | |
| 3 | -$4.59M | |
| 4 |
CC
Chicago Capital
Chicago,
Illinois
|
-$4.48M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$2.41M |